Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

GNBT Relative to the S&P 500

GNBT Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Generex Biotechnology Corp. (OTCMKT:GNBT) seasonal charts above shows that a Buy Date of January 1 and a Sell Date of March 28 has resulted in a geometric average return of 9.23% above the benchmark rate of the S&P 500 Total Return Index over the past 19 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is a fair rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 19 years by an average of 37.97% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Generex Biotechnology Corp is engaged in the research and development of drug delivery systems and technologies. It mainly focuses on developing technology for the administration of formulations of large molecule drugs to the oral (buccal) cavity.

Stocks mentioned in this post: GNBT